Document is current
Any future updates will be listed below
-
Authors
Afshar, Kambiz
Fleischmann, Nina
Schmiemann, Guido
Bleidorn, Jutta
Hummers-Pradier, Eva
Friede, Tim
Wegscheider, Karl
Moore, Michael
Gágyor, Ildikó
-
Funding
Funding for this research was provided by:
Bundesministerium für Bildung und Forschung (FK 01KG1601)
- License Information
-
More Information
Article History
Received: 22 August 2017
Accepted: 22 June 2018
First Online: 3 July 2018
Ethics approval and consent to participate
: Ethical approval has been obtained by the Independent Ethics Committees of the University Medical Center Göttingen (No. 16/11/16). Informed written consent will be obtained from all participants prior to any trial-related procedures.
: Not applicable.
: The authors have no conflicts of interest to declare. Haupt Pharma Wulfing GmbH was contracted to produce and repack the trial medication (Arctuvan®). The company did not have influence on the study design and will participate neither in the clinical project management nor in the collection, analysis, and interpretation of data.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
